Intestinal flora is a commensal microbial community in the intestinal tract of human body. many studies have proved that the imbalance of intestinal flora is closely related to many diseases. The correlation between heart failure and intestinal flora is a hot topic in medical research nowadays. The imbalance of intestinal flora is closely related to the occurrence and development of heart failure. A large number of studies have shown that TCM treatment can play a role in the treatment of heart failure by restoring intestinal homeostasis and regulating the types of flora and the level of metabolites, which has been widely used in the prevention and treatment of heart failure.

Danyang Hao, Xuebin Chen, Bairong Wang. Research Progress of Correlation between Regulating Intestinal Microflora Disorder and Heart Failure in TCM and Western Medicine. Frontiers in Medical Science Research (2023) Vol. 5, Issue 8: 123-129. https://doi.org/10.25236/FMSR.2023.050817.

[1] Guo Jintao, Meng Qingshu, Fan Huimin, Liu Zhongmin. V Research progress on the role of intestinal flora imbalance in heart failure [J]. Advances in Cardiology, 2018, 39 (04): 619-622. DOI: 10. 16806/J. CN KI. ISSN. 1004-3934. 2018. 04. 028. 

[2] Nagatomo Y, Tang W H. Intersections between microbiome and heart failure:revisiting the gut hypothesis [J]. J Card Fail, 2015, 21(12):973[980]. 

[3] Guo Shasha, Chen Haoyu, Li Yan, Su Wenge. Exploration of the correlation between intestinal microecology and heart failure based on the theory of "correlation between heart and spleen" [J]. Journal of Shandong University of Chinese Medicine, 2020, 44 (03): 267-271. DOI: 10. 16294/j. CN KI. 1007-659 x. 2020. 03. 009. 

[4] Zhang Guang, Luo Fuli, Dong Bicheng, Wu Guoqing. Research progress on correlation between regulation of intestinal flora and CKD in TCM and western medicine [J]. Asia Pacific Traditional Medicine, 2021, 17(09):176-179. 

[5] Wu Wenjuan, Wu Jizhen, Huang Gairong, Qian Peng, Zhang Guojun. Study on the correlation between intestinal flora imbalance and heart failure in elderly patients with idiopathic pulmonary fibrosis [J]. Chinese Journal of Geriatric Cardio-Cerebrovascular Diseases, 2022, 24(01):14-16. 

[6] Jia Shuwei, Wu Zhenli. Intestinal flora imbalance and heart failure [J]. Journal of Microcirculation, 2019, 29(04):74-77. 

[7] Iacob S, Iacob DG. Infectious threats, the intestinal barrier, and its trojan horse:dysbiosis[J]. Front Microbiol, 2019, 10:1676. 

[8] Wu Ningbo, Sun Hongxiang, Zhao Xiaoyun, et al. MAP3K2-regulated intestinal stromal cells define distinct stem cell niche[J]. Nature, 2021, 592(7855):606-610. 

[9] Guo Chunjun. Immune activation kickstarts the gut microbiota[J]. Cell Host Microbe, 2021, 29(3): 318-320. 

[10] Sandek A, Swidsinskia, Schroedl W, et al. Intestinal blood flow in patients with chronic heart failure:a link with bacterial growth, gastrointestinal symptoms, and cachexia[J]. J Am Coll Cardiol, 2014, 64(11):1092-1102. 

[11] Pasini E, Aquilani R, Testa C, et al. Pathogenic gut flora in patients with chronic heart failure [J]. Jacc Heart Fail, 2016, 4(3):220-227. 

[12] Jia Shuwei, Wu Zhenli. Intestinal flora imbalance and heart failure [J]. Journal of Microcirculation, 2019, 29(04):74-77+82. 

[13] Deng Xinyi, Jiang Hong, Li Xianlun. Research progress on the association of intestinal flora with heart failure [J]. China Medical Journal, 2020, 55(12):1301-1303. 

[14] Xiong Yanhua, Zeng Wenping, Fang Juan. Relationship between the severity of chronic heart failure and intestinal flora in the elderly [J]. China Journal of Microecology, 2021, 33 (06): 662-665+669. DOI: 10. 13381/j. CN Ki. CJM. 202106008. 

[15] Li Guojing, Liu Lingmei. Research progress on the relationship between intestinal flora changes and heart failure [J]. Internal Medicine, 2021, 16 (05): 643-645. 

[16] Zhong Shishun. Intestinal mucosal barrier dysfunction and Bifidobacterium [J]. Foreign Medicine (Physiology, Pathology and Clinical), 2003, (04):432-435. 

[17] Qian Shaohuan, Kang Pinfang, Wang Hongju. Research progress of intestinal flora and cardiovascular disease [J]. Journal of Qiqihar Medical College, 2020, 41(08):1000-1002. 

[18] Tang W H, Wang Z, Fan Y. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure[J]. Journal of the American College of Cardiology, 2014, 64:1907-1914. 

[19] Goverse G, Molenaar R, Macia L, et al. Diet-derived short chain fatty acids stimulate intestinal epithelial cells to induce mucosal tolerogenic dendritic cells[J]. J Immunol, 2017, 198(5):2172-2181. 

[20] Chen Mingtai, Li Meihuan, Zhang Jian, Zhong Zhang, Luan Jienan. Exploration of the relationship between cardiovascular disease and intestinal microecology based on the theory of "the heart and the small intestine exterior-interior" [J]. World Chinese Medicine, 2020, 15(19):2920-2926. 

[21] Zhang Zhonghe, Xia Hao. Research progress on the relationship between short-chain fatty acids and cardiovascular disease [J]. Journal of Chinese PLA Medicine, 2020, 32(10):112-116. 

[22] Chen Xi, Li Hanyu, Hu Xiaomin, et al. Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure[J]. Chinese Medical Journal, 2019, 132(15): 1843-1855. 

[23] Vinolo MA, Rodrigues HG, Nachbar RT, et al. Regulation of inflammation by short chain fatty acids [J]. Nutrients, 2011, 3(10):858-876. 

[24] Yang Fei, Wang Congyu, Wang Lin, Wang Junkui, Liu Fuqiang, Ji Xincai. Advances in the study of heart failure and intestinal flora imbalance [J]. Journal of Clinical Internal Medicine, 2020, 37(02): 142-144. 

[25] von HS, Schefold JC, Jankowska EA, et al. Ursodeoxycholic acid in patients with chronic heart failure:a double-blind, randomized, placebo-controlled, crossover trial[J]. Journal of the American College of Cardiology, 2012, 59(6):585-592. 

[26] Zhuang Jing, Wang Ruiping. Exploration on the correlation between the theories of heart and spleen and the brain-gut axis [J]. China Journal of Traditional Chinese Medicine Information, 2019, 26(09): 12-14. 

[27] Zhang Chenyang, Liu Tianhao, Wang Wei, Yao Zheng, Yi Yang, Xiao Qian, Chen Wenhui. On intestinal microenvironment as an important biological basis for the treatment of liver disease from the spleen [J]. Chinese Journal of Traditional Chinese Medicine, 2019, 34(07):2877-2880. 

[28] He Yunshan, Hui Huaying, Tan Zhoujin. The role of characteristic intestinal flora of spleen and stomach diseases in TCM diagnosis and treatment [J]. World chinese journal of digestology, 2019, 27(10): 605-610. 

[29] Jiang Xiaoyan, Xie Weichang, Zhou Daqiao, Li Jian, Guo Shaoju, Huang Bin. Effect of Lichang Decoction on intestinal microecology, metabolites and inflammatory factors in patients with ulcerative colitis of spleen deficiency and dampness stagnation type [J]. New traditional chinese medicine, 2019, 51(02):142-146. 

[30] Li Qiuming, Zhang Yajie, Zhang Dafang, Liu Jia, Li Lijing. The microecological regulation of Spleen-Strengthening antidiarrheal granule on mouse model of spleen deficiency and imbalance of antibiotic intestinal flora [J]. China Journal of Basic Medical Science of Traditional Chinese Medicine, 2010, 16(12):1119-1120. 

[31] Lin Tianyao. Study on the mechanism of Cai's Spleen-Strengthening Tongbian Decoction in the treatment of constipation due to spleen deficiency and long-term clinical efficacy observation [D]. Guangzhou: Guangzhou University of Traditional Chinese Medicine, 2017:

[32] Zhao Dandan, Qu Huiyan, Yang Tianshu, Zhang Xiaoqing, Yang Tao, Zhou Hua. Overview of research on the regulation of intestinal flora in the prevention and treatment of heart failure by traditional Chinese medicine [J]. Journal of Cardio-Cerebrovascular Diseases of Integrated Chinese and Western Medicine, 2021, 19(03):438-441.